Ebi N - Search Results

1

A Novel Preservation Solution Containing a JNK Inhibitory Peptide Efficiently Improves Islet Yield for Porcine Islet Isolation.

Noguchi H, Miyagi-Shiohira C, Nakashima Y, Ebi N, Hamada E, Tamaki Y, Kuwae K, Kitamura S, Kobayashi N, Saitoh I, Watanabe M. Noguchi H, et al. Among authors: ebi n. Transplantation. 2019 Feb;103(2):344-352. doi: 10.1097/TP.0000000000002555. Transplantation. 2019. PMID: 30557272

2

Comparison Between Modified Extracellular-Type Trehalose-Containing Kyoto Solution and University of Wisconsin Solution in 18-Hour Pancreas Preservation for Islet Transplantation.

Hamada E, Ebi N, Miyagi-Shiohira C, Tamaki Y, Nakashima Y, Kobayashi N, Saitoh I, Watanabe M, Kinjo T, Noguchi H. Hamada E, et al. Among authors: ebi n. Pancreas. 2018 Aug;47(7):e46-e47. doi: 10.1097/MPA.0000000000001104. Pancreas. 2018. PMID: 29985851 No abstract available.

3

Modified cell-permeable JNK inhibitors efficiently prevents islet apoptosis and improves the outcome of islet transplantation.

Noguchi H, Miyagi-Shiohira C, Nakashima Y, Ebi N, Hamada E, Tamaki Y, Kuwae K, Kobayashi N, Saitoh I, Watanabe M. Noguchi H, et al. Among authors: ebi n. Sci Rep. 2018 Jul 23;8(1):11082. doi: 10.1038/s41598-018-29481-9. Sci Rep. 2018. PMID: 30038242 Free PMC article.

4

Evaluation of Islet Purification Methods for Making a Continuous Density Gradient and Loading Tissue.

Ebi N, Miyagi-Shiohira C, Hamada E, Tamaki Y, Masamoto M, Makishi E, Nakashima Y, Kobayashi N, Saitoh I, Watanabe M, Noguchi Y, Kinjo T, Noguchi H. Ebi N, et al. Cell Med. 2018 May 29;10:2155179017733090. doi: 10.1177/2155179017733090. eCollection 2018. Cell Med. 2018. PMID: 32634178 Free PMC article.

5

A Comparison of Pancreatic Islet Purification using Iodixanol with University of Wisconsin Solution and with Na-Lactobionate and Histidine Solution.

Nakashima Y, Miyagi-Shiohira C, Ebi N, Hamada E, Tamaki Y, Kuwae K, Kobayashi N, Saitoh I, Watanabe M, Kinjo T, Noguchi H. Nakashima Y, et al. Among authors: ebi n. Cell Med. 2018 Jun 7;10:2155179018775071. doi: 10.1177/2155179018775071. eCollection 2018. Cell Med. 2018. PMID: 32634189 Free PMC article.

6

Comparison of Tissue Loading Before and After the Creation of a Continuous Density Gradient in Porcine Islet Purification.

Miyagi-Shiohira C, Nakashima Y, Ebi N, Hamada E, Tamaki Y, Kuwae K, Kobayashi N, Saitoh I, Watanabe M, Kinjo T, Noguchi H. Miyagi-Shiohira C, et al. Among authors: ebi n. Cell Med. 2018 Jun 29;10:2155179018781343. doi: 10.1177/2155179018781343. eCollection 2018. Cell Med. 2018. PMID: 32634190 Free PMC article.

7

Immunotherapy With Radiotherapy for Brain Metastases in Patients With NSCLC: NEJ060.

Tozuka T, Minegishi Y, Yamaguchi O, Watanabe K, Toi Y, Saito R, Nagai Y, Tamura Y, Shoji T, Odagiri H, Ebi N, Sakai K, Kanaji N, Izumi M, Soda S, Watanabe S, Morita S, Kobayashi K, Seike M. Tozuka T, et al. Among authors: ebi n. JTO Clin Res Rep. 2024 Feb 20;5(4):100655. doi: 10.1016/j.jtocrr.2024.100655. eCollection 2024 Apr. JTO Clin Res Rep. 2024. PMID: 38706978 Free PMC article.

8

Survival Impact of Second-Line Immune Checkpoint Inhibitors in Older Patients With Advanced Squamous-Cell NSCLC: Post Hoc Analysis of the CAPITAL Study.

Kogure Y, Kada A, Hashimoto H, Atagi S, Takiguchi Y, Saka H, Ebi N, Inoue A, Kurata T, Fujita Y, Nishii Y, Itani H, Endo T, Saito AM, Shibayama T, Yamamoto N, Gemma A. Kogure Y, et al. Among authors: ebi n. JTO Clin Res Rep. 2023 Apr 6;4(6):100514. doi: 10.1016/j.jtocrr.2023.100514. eCollection 2023 Jun. JTO Clin Res Rep. 2023. PMID: 37304652 Free PMC article.

9

Real-world Efficacy and Safety of Atezolizumab Plus Bevacizumab, Paclitaxel and Carboplatin for First-line Treatment of Japanese Patients With Metastatic Non-squamous Non-small Cell Lung Cancer.

Ikeuchi N, Igata F, Kinoshita E, Kawabata T, Tan I, Osaki Y, Otsuka R, On R, Ikeda T, Nakao A, Sasaki T, Aoyama T, Hirano R, Harada T, Ebi N, Fujita M, Inoue H. Ikeuchi N, et al. Among authors: ebi n. Anticancer Res. 2023 Feb;43(2):713-724. doi: 10.21873/anticanres.16210. Anticancer Res. 2023. PMID: 36697078

10

Efficacy and safety of carboplatin with nab-paclitaxel versus docetaxel in older patients with squamous non-small-cell lung cancer (CAPITAL): a randomised, multicentre, open-label, phase 3 trial.

Kogure Y, Iwasawa S, Saka H, Hamamoto Y, Kada A, Hashimoto H, Atagi S, Takiguchi Y, Ebi N, Inoue A, Kurata T, Okamoto I, Yamaguchi M, Harada T, Seike M, Ando M, Saito AM, Kubota K, Takenoyama M, Seto T, Yamamoto N, Gemma A. Kogure Y, et al. Among authors: ebi n. Lancet Healthy Longev. 2021 Dec;2(12):e791-e800. doi: 10.1016/S2666-7568(21)00255-5. Lancet Healthy Longev. 2021. PMID: 36098037 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

55 results

Search Page